Sonder Capital | Futures II

◆ Location

United States

◆ Activity

Statusactively investing

◆ Links

◆ Investment Thesis

Focus on AI-enabled medical robotics and minimally invasive therapies, fueling companies creating entirely new care pathways and business models to create new standards of care in distributed settings.

◆ About Sonder Capital

Early-stage venture capital firm investing in medical device, diagnostic, and healthtech companies; describes itself as a foundational investor that supports companies from inception to acquisition or IPO.

◆ Sectors

MedtechRoboticsGenerative AIDiagnosticsDigital Health

◆ Stages

seedseries-aseries-b

◆ Geography Focus

global

◆ Team

Name	Title	Role	Links
Andy McGibbon	Partner	—
Colby Wood	Co-Founder and Partner, Capital Formation	—
Deborah Kilpatrick, Ph.D.	Venture Partner	—	in
Fred Moll, M.D.	Co-Chair and Partner	—	in
Jay Watkins	Co-Chair and Partner	—

◆ Notable Investments

VitestroWondr MedicalGI WindowsAvail

◆ FAQ

What does Futures II invest in?

Futures II invests in Medtech, Robotics, Generative AI, Diagnostics and Digital Health at the seed, series-a and series-b stages.

Which geographies does Futures II focus on?

Futures II focuses on global, and is headquartered in United States.